M54.51, Vertebrogenic low back painICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
CGS-J15-L36029, Urine Drug Testing
J15
CGS-J18-L36029, Urine Drug Testing
J18
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
A59553, Billing and Coding: Trigger Point Injections
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
NGS-J6-L39611, Urine Drug Testing
J6
A59487, Billing and Coding: Trigger Point Injections (TPI)
J6
NGS-J6-L40302, Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
J6
NGS-J6-L40301, Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
J6
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
A59416, Billing and Coding: Urine Drug Testing
J6
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
FIRST_COAST-L36393, Controlled Substance Monitoring and Drugs of Abuse Testing
J9
FIRST_COAST-L33674, Duplex Scanning
J9
A57077, Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
J9
A57636, Billing and Coding: Duplex Scanning
J9
NOVITAS-JH-L35006, Controlled Substance Monitoring and Drugs of Abuse Testing
JH
NGS-JK-L39611, Urine Drug Testing
JK
NGS-JK-L40302, Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
JK
NGS-JK-L40301, Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain
JK
NOVITAS-JL-L35006, Controlled Substance Monitoring and Drugs of Abuse Testing
JL